Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Lexeo Therapeutics (LXEO) Accumulated Depreciation & Amortization (2022 - 2026)

Lexeo Therapeutics' Accumulated Depreciation & Amortization history spans 2 years, with the latest figure at $381000.0 for Q4 2023.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 186.47% to $381000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $381000.0, a 186.47% increase, with the full-year FY2023 number at $381000.0, up 186.47% from a year prior.
  • Accumulated Depreciation & Amortization hit $381000.0 in Q4 2023 for Lexeo Therapeutics, up from $316000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for LXEO hit a ceiling of $381000.0 in Q4 2023 and a floor of $133000.0 in Q4 2022.